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Abstract  
 
Cells are constantly exposed to Reactive Oxygen Species (ROS) produced both endogenously 
to meet physiological requirements and from exogenous sources. While endogenous ROS are 
considered as important signaling molecules, high uncontrollable ROS are detrimental. It is 
unclear how cells can achieve a balance between maintaining physiological redox 
homeostasis and robustly activate the antioxidant system to remove exogenous ROS. We 
have utilized a Systems Biology approach to understand how this robust adaptive system 
fulfills homeostatic requirements of maintaining steady-state ROS and growth rate, while 
undergoing rapid readjustment under challenged conditions. Using a panel of human ovarian 
and normal cell lines, we experimentally quantified and established interrelationships 
between key elements of ROS homeostasis. The basal levels of NRF2 and KEAP1 were cell 
line specific and maintained in tight correlation with their growth rates and ROS. 
Furthermore, perturbation of this balance triggered cell specific kinetics of NRF2 nuclear-
cytoplasmic relocalisation and sequestration of exogenous ROS. Our experimental data were 
employed to parameterize a mathematical model of the NRF2 pathway that elucidated key 
response mechanisms of redox regulation and showed that the dynamics of NRF2-H2O2 
regulation defines a relationship between half-life, total and nuclear NRF2 level and 
endogenous H2O2 that is cell line specific. 
 
Key words: Proliferation, ROS, Oxidative Stress, NRF2 localisation, Mathematical 
Modelling 
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1. Introduction 
 
Proliferation is an intrinsic component of cellular growth and development that is tightly 
coupled to the state of a cell, and especially metabolism, and its environmental context (Fritz 
et al., 2010). This mix of internal and external conditions often results in the generation of 
both endogenous and exogenous free radicals in the form of reactive oxygen species (ROS). 
ROS are highly reactive molecules, often in the form of hydroxyl radical (OH
-
), hydrogen 
peroxide (H2O2) and superoxide (O2
-
) as well as reactive nitrogen species. ROS can cause 
damage to cellular macromolecules such as DNA, proteins and lipids when not sequestered 
and managed (Brieger et al., 2012). Thus ROS exert oxidative stress and create redox 
perturbations in the cell that manifest through antioxidant defences until the restoration of 
redox homeostasis.  
 
Cells have developed and evolved coordinated mechanisms of sensing and signalling to 
respond to, and even intrinsically and extrinsically tolerate and adapt to ROS (Hamanaka et 
al., 2010; Martin et al., 2002). This is because low, graded and tolerable levels of ROS are 
key determinants and modulators of intracellular signalling pathways that govern and 
determine cellular proliferation in particular, and also differentiation, migration, 
developmental progression (from stemness to adulthood) and lifespan (D'Autréaux et al., 
2007; Holmström et al., 2014; Martin et al., 2002). Thus ROS have acquired the status of 
second messengers in signal transduction pathways (Finkel, 2011; Rigoulet et al., 2011). In 
contrast, high levels of ROS are difficult to control and can lead to cellular accumulation of 
mutations and the acceleration of disease, ageing and death (Brieger et al., 2012). 
Biochemical strategies to curb ROS can be broadly grouped into non-enzymatic (low 
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molecular weight) scavengers, such as glutathione (GSH), coenzyme Q, and lipoic acid, and 
enzymatic antioxidant defense systems that include superoxide dismutases, catalases, 
peroxidases, thioredoxins, peroxiredoxins and reductases (Nordberg et al., 2001; Sies, 1997). 
The strategies extend to connect to several other oscillatory systems and pathways that 
coordinate and transduce signals to effector molecules or cellular compartments (Circu et al., 
2010). Overall, levels of one antioxidant system cause compensatory alterations in the levels 
of the others, together with other associated pathways, to restore redox homeostasis that 
transduce into a multitude of pathways leading to different physiological consequences 
(Valko et al., 2007).  
 
The extensive and complex manner in which the redox network and its interconnections 
influence cellular proliferation is challenging to understand. Importantly, extensive research 
over the last decade has systematically unravelled the details of a gene regulatory network 
that centres on a specific trans-acting regulatory factor known as nuclear erythroid 2-related 
factor, NRF2 (Niture et al., 2013). NRF2 drives both the basal and inducible transcription of 
genes associated with redox homeostasis and cytoprotection, as well as other signal 
transduction pathways (Jaiswal, 2004). This is achieved by heterodimerising with small MAF 
proteins and binding to some cis-acting factors called Antioxidant Response Elements 
(AREs) or electrophile response elements (EpREs) within the promoters of these genes 
(Kimura et al., 2007; Li et al., 2008). Under normoxic conditions, little free NRF2 is 
available in the cytoplasm and for translocation to the nucleus to drive the basal transcription 
of target genes. Most of the remaining cytosolic NRF2 is anchored by KEAP1, a cytoplasmic 
NRF2-binding adaptor and sensor protein, which tethers NRF2 for association with the Cul3-
based E3 ubiquitin ligase to promote its degradation by the 26S proteasome (Kaspar et al., 
2009).  
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Under oxidative stress or in the presence of NRF2 inducers, a number of cysteine residues of 
KEAP1 become oxidised to cause conformational changes in the KEAP1 structure. This 
allows NRF2 to escape from being targeted by the 26S proteasomal degradation machinery 
and to accumulate in the nucleus to further induce the transactivation of ARE-containing 
genes in order to restore redox homeostasis (Kobayashi et al., 2005). Biochemical and 
structural analyses have revealed the existence of a cherry-bob structure in which one 
molecule of NRF2 associates with two molecules of KEAP1 via two binding sites (hinge and 
latch model) within the Neh2 domain of NRF2. This model is supported and extended by the 
recent proposed cyclic sequential attachment and regeneration model of KEAP1-mediated 
degradation of NRF2 (Baird et al., 2013; Ogura et al., 2010; Tong et al., 2006). Several other 
mechanisms of perturbing and controlling the cellular NRF2-KEAP1 dynamics in relation to 
ROS also exist and are supported by both in vitro and in vivo models (Cullinan et al., 2004, 
Furukawa et al., 2005, Yamamoto et al., 2008). Importantly here, NRF2-KEAP1 mutations 
and other perturbations leading to permanent constitutive adaptive activation of the NRF2 
pathway are increasingly observed in cancers (Hayes et al., 2009, Shibata et al., 2008, Ohta et 
al., 2008) and other diseases (Satoh et al., 2009; Wakabayashi et al., 2003). It is well known 
that several therapeutic strategies, for example anticancer radiotherapy and chemotherapy, 
largely depend on ROS manipulation to induce cytotoxicity. More recently, there is a 
growing body of evidence implicating NRF2 and ROS in the promotion of cellular 
proliferation and therapeutic resistance in cancer cells (Homma et al., 2009, Hu et al., 2005; 
Lister et al., 2011; Reddy et al., 2007; Ruiz-Ginés et al., 2000).  
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A key step in understanding the effect of ROS on cell behaviour and the consequence of its 
alteration to meet particular physiological requirements is the identification and 
characterisation of signalling pathways that detect and respond to ROS and subsequently 
initiate appropriate responses. Thus cellular tolerance, selectivity and ROS manipulation 
strategies to impact the fate of both normal and diseased cells may depend on their individual, 
heterogeneous net redox status and its potential to restore its balance upon perturbation. It is 
practically difficult to measure precisely all forms of ROS within and around the cellular 
microenvironment and compartments, as well as assessing the redox protective and repair 
potential of cells over time. Previous work has investigated a range of different aspects of the 
antioxidant defence systems to model cellular proliferation and redox homeostasis either in 
general or surrounding the NRF2 pathway (Aon et al., 2010; Gauthier et al., 2013; Hamon et 
al., 2014; Selivanov et al., 2011; Taylor et al., 2008). It is clear that the cellular redox 
potential and the associated dynamics of changing ROS levels in various cellular 
compartments and organelles are intricately interconnected with the operation of the redox 
homeostatic regulatory network. This regulatory network comprises ROS itself as well as 
transcriptional, translational and post-translational elements of regulation. All these elements 
converge on a NRF2-centred adaptive system, which thus presents itself as an appealing and 
measurable system to model ROS production and sequestration and make predictions. The 
NRF2-centred system serves as a key redox interconnectivity node and interface between 
ROS and the regulation of functioning in a broad spectrum of cellular physiological and 
pathological processes including proliferation. 
 
In line with this NRF2 focus, we have profiled the proliferation of normal epithelial 
keratinocytes (HaCaT) and a panel of ovarian (OVCAR3, OVCAR4, PEO1, PEO4, PEO6 
and SKOV3) cancer cell lines under both basal and perturbed redox status. We have 
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quantified and evaluated the dynamics of ROS production and sequestration capacity, as well 
as the levels, stability and localisation of NRF2 and the basal expression of KEAP1 in these 
cell lines. We have used our experimental data, in conjunction with experimental data 
regarding oxidative stress responses and the NRF2-KEAP1 pathway by others (Malhotra et al 
2010;) to mathematically model oxidative stress. The model accounts for the major 
components that interdependently feed into and out of the NRF2-centred network to sequester 
ROS. The model integrates NRF2-KEAP1 signalling in the cytoplasm and genetic regulation 
of NRF2-dependent antioxidative enzymes and involves negative feedback between these 
two control systems. Through this minimal integrative model of cellular oxidative stress 
responses due to ROS we explore the link between the ROS scavenging system  and our 
existing knowledge of the NRF2-centred adaptive system.  
 
 
 
 
2. Materials and Methods 
 
2.1 Experimental Methods 
 
2.1.1 Cell lines, culture conditions and treatments   
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Immortalised human keratinocytes (HaCaT) were maintained in DMEM while human 
ovarian cancer cell lines PEO1, PEO4, PEO6, SKOV3, OVCAR3 and OVCAR4 were 
maintained in RPMI 1640 (Gibco® Invitrogen, UK) both media supplemented with 10% 
foetal bovine serum (FBS), 2 mM glutamine, 1 mM sodium pyruvate, 100 μg/ml 
streptomycin and 100U/ml penicillin in an atmosphere of 5% CO2. For reducing conditions, 
100mM N-Acetyl Cysteine (Sigma-Aldrich) was prepared in deionised water and diluted to a 
final concentration of 10mM with media during treatments. For oxidative stress conditions, 
30% H2O2 (Sigma-Aldrich) was diluted in deionised water to prepare 10mM stock on the day 
of treatment and was further diluted in media to different concentrations depending upon type 
of experiments. 
 
2.1.2 ROS detection assays 
 
The H2O2 detection assay was performed using 10-acetyl-3,7-dihydroxyphenoxazine 
(Amplex® Red reagent, Invitrogen) following the manufacturer’s protocol. Briefly, cells 
were seeded at a density of 5 x 10
3
 cells/well in 50 μl media without phenol red and were 
allowed to grow in opaque flat bottom 96-well tissue culture plates. On the day of assay, the 
Amplex® Red reagent was diluted in DMSO (Fisher Bioreagents) to obtain a stock 
concentration of 10 mM, while 10 U/ml of Horse Radish Peroxidase (HRP) was prepared in 
the provided 1x reaction buffer.  At the time of H2O2 detection, a working stock of 100 μM 
Amplex® Red and 0.2 U/ml of HRP was prepared in 50 μl reaction buffer and added directly 
onto cells with media in each well of the 96-well plate. The plates were incubated for 30 
minutes (min) at 37°C followed by taking readings using 96-well fluorescent multi plate 
reader (MODULUS
TM
, Promega) using excitation and emission spectra of 530/590nm. To 
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estimate actual H2O2 levels from the signals obtained above, standard calibration curves for 
H2O2 were established by preparing serial dilutions of 20 μM H2O2 in 50 μl volume each in a 
96-well plate and adding 50μl of Amplex® Red/HRP reagent prepared as above and 
following the same protocol onwards for detection.  
 
For the detection of H2O2 neutralisation/degradation kinetics for different cells, H2O2 
reduction assay was designed. For this, 1× 10
4 
cells were seeded in a flat bottom 96-well 
tissue culture plate in 100 μl media. Next day, cells were washed with warm PBS and 50 μl 
of new media (without phenol red) containing 5 μM H2O2 was added. At different time points 
after addition of H2O2, media from each well was transferred to a new opaque 96-well plate 
and 50 μl of the Amplex® Red reagent prepared as above was added. The plate was 
incubated for 30 min at 37° C and readings were taken as above.  
 
For total cellular ROS detection, CellROX® Green reagent (Invitrogen) was used. Briefly, 1× 
10
4 
cells were seeded in opaque 96-well tissue plates and allowed to attach for 18 h. At the 
time of assay, CellROX® Green reagent was transferred into each well containing cells and 
media to achieve 5 µM concentration and allowed to incubate at 37°C for 30 min. Following 
this, cells were washed thrice with PBS and immediately analysed for fluorescent signal in 
96-well plate reader (Modulus template, Promega) using excitation and emission spectra of 
485/520 nm or imaged with a Leica DMiRe2 electronic microscope under relevant channel.  
 
2.1.3 Total protein extraction, protein half-life and sub cellular fractionation 
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For quantitative immunoblotting, cells were seeded in 60 mm tissue culture plates and grown 
until 70% confluent. At the time of protein harvest, cells were trypsinized (Gibco® 
Invitrogen), washed with PBS and counted using haemocytometer. Protein lysates were 
prepared from 1× 10
6
 cells using RIPA buffer (Pierce Biotech) supplemented with protease 
and phosphatase inhibitor cocktail (Pierce Biotech) and subjected to sonication of 2 cycles for 
10 s at 50% pulse. The final mixture was shaken gently on ice for 15 min and the protein 
supernatant was obtained by centrifuging the lysates at 14,000 x g for 15 min. The proteins 
were quantified by Bradford assay (Sigma-Aldrich) using BSA as a standard and sample 
buffer (Nupage LDS, Invitrogen) was added to protein lysates, heated at 70°C for 20 min and 
stored at -20°C until needed. 
 
To study protein half-life, cells were seeded as above and once 70% confluent, were exposed 
to 50 μM of protein synthesis inhibitor Cycloheximide (CHX) (Sigma-Aldrich). At different 
time points following CHX addition, cells were processed for immunoblotting as above.  
To prepare nuclear and cytoplasmic fractions, cells were lysed in ice-cold hypotonic buffer 
(10 mM KCl, 0.1 mM EGTA, 0.1 mM EDTA, 10 mM HEPES pH 8, 1 mM DTT, 0.5 mM 
PMSF, 1 mg/ml aprotinin, 1 mg/ml leupeptin, 1 mg/ml pepstatin, 0.1 mM Na3VO4), 
centrifuged and the resulting supernatant (cytosolic fraction) was immediately analyzed or 
stored at 80°C until needed. To obtain nuclear fractions, the pellet was briefly washed thrice 
in ice-cold hypertonic buffer (0.4 M NaCl, 1 mM EGTA, 1 mM EDTA, 20 mM Hepes pH 
8.0, 1 mM DTT, 1 mM PMSF, 1 mg/ml aprotinin, 1 mg/ml leupeptin, 1 mg/ml pepstatin, 0.1 
mM Na3VO4), followed by incubation in hypertonic buffer for 30 min at 4°C, and 
centrifugation (13,000 x g, 5 min, 4°C). The supernatant (nuclear fraction) was immediately 
analyzed or stored at 80°C until used. Subsequently all protein extracts were quantified using 
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the Bradford reagent as a before. Verification of the quality of sub-cellular fractions was done 
by performing immunoblotting using antibodies specific to nuclear and cytoplasmic marker 
proteins.  
 
To determine absolute abundance of NRF2 and Keap-1 in cells, quantitative immunoblotting 
was performed and calibrated against known concentrations of respective recombinant 
proteins standards (Novus Biologicals). Briefly, serial dilutions of known concentrations of 
standard recombinant proteins were made using Nupage sample buffer (Invitrogen) and the 
proteins loaded onto SDS polyacrylamide gels for subsequent immunoblotting. The 
immunoblot signal detected for each of the known standard sample was used to establish a 
standard curve against which the concentration of immunoblot signal from test samples was 
calculated.  
 
2.1.4 Immunoblotting 
Prepared protein lysates as stated above were loaded into wells of 10% SDS-polyacrylamide 
gels and subjected to electrophoresis at 200 Volts for 1-2h.  Then proteins were transferred 
onto polyvinylidene difluoride membranes (GE Amersham) using the XCell SureLock Mini-
Cell system (Invitrogen) at 50 Volts for 90 min and processed using a commercially available 
kit (WesternBreeze™ Chromogenic Immunodetection Kit, Invitrogen).   
 
Non-specific reactivity was blocked by incubation with the blocking reagent supplied in the 
kit. Membranes were further treated by incubating with primary antibodies (Table 1) for 2 h 
at room temperature or overnight at 4
o
C, followed by incubation for 30 min at room 
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temperature with appropriate secondary anti mouse or anti rabbit antibody supplied in the kit. 
Bands were visualized with the BCIP/NBT based chromogenic substrate. For loading control, 
immunoblotting of the same lysates was performed using β-Actin antibody (Abcam 
Bioscience, UK).  
 
2.1.5 Proliferation assay 
The proliferation assay was performed by seeding 2 × 10
4 
cells in triplicates in complete 
media per well in 24-well plate. This was considered as day 0. Following this, cells were 
trypsinized and counted from each well individually for 6 days and cell numbers were plotted 
against each day and analysed. For proliferation assay under reducing or oxidative stress 
conditions, cells were seeded (day 0) and maintained continuously in media containing 10 
mM N-Acetyl Cysteine or 20 µM H2O2 (Sigma-Aldrich) and cells counted each day for 6 
days.  
 
2.1.6 Immunocytochemistry/Immunolabelling 
 
For immunocytochemistry, exponentially growing cells were seeded at a density of 5 ×10
4
 
cells in complete media onto poly-L lysine (Sigma-Aldrich) coated cover slips placed in a 12-
well tissue culture plates. The next day, following relevant treatments, cells were washed 
three times with ice cold PBS, fixed in 3.5% paraformaldehyde in a standard PBS at room 
temperature for 30 min. Then cells were gently washed twice with 1 ml of PBS, 
permeabilized with 0.3% triton X-100 for 10min, and following three washed with PBS, 
blocked with 1% goat serum, 1% bovine serum albumin in PBS containing 0.05% Triton X-
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100 for 30 min. Cells were then incubated with relevant primary antibody (Table 1) diluted in 
blocking solution for 1 h, washed three times with 0.1% Triton X-100/PBS for 5 min, and 
then incubated with Alexa Fluor 488/568- conjugated goat anti-rabbit or anti mouse 
antibodies (Invitrogen, UK) for 30 min. Staining for F-Actin was performed by using Alexa 
fluor 568 conjugated Phalloidin (Invitrogen) according to manufacturers’ instructions. After 
subsequent washing three times with the 0.1% Triton X-100/PBS for 5 min, cover slips with 
cells were mounted on slide using 4',6-Diamidino-2-Phenylindole, Dihydrochloride (DAPI)-
containing mounting reagent (Vectashield, Vector Laboratories) and imaged under relevant 
filters with a Leica DMiRe2 electronic microscope.  
 
2.1.7 Imaging and analysis 
 
Quantitative analysis of raw immunoblots was performed by capturing the images in high 
resolution TIFF format files using a charge-coupled-device camera (AxioCam MRc, Carl 
Zeiss) and subjected to Gelpro analysis software, version 3.1 (Gelpro Media Cybernetics) for 
densitometry. Fluorescence images of immunocytochemistry were collected under relevant 
excitation and emission filters depending on the fluorotype under Leica DMiRe2 electronic 
microscope equipped with iXonEM +897 EMCCD camera (ANDOR Technologies Ltd). 
Images were visualised using multidimensional microscopy software Andor Module iQ Core. 
Colocalization assays and fluorescence intensity measurements were performed and 
determined with software integral features supplied by Andor IQ core software. Data were 
generally expressed as mean ± S.E.M. for individual sets of experiments. 
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2.1.8 Statistics 
 
All statistical analysis were performed using the software SPSS (IBM, version 22). Tests for 
normality of data were determined by Shapiro-Wilk and by Kolmogorov and Smirnov tests. 
For correlational analysis, either Pearsons or Spearmans two tailed or one-tailed tests were 
performed.  
 
2.2 Computational Methods 
 
The experimental data was analysed using a computational model describing the NFR2-
KEAP1-dependent mechanism of redox homeostasis regulation and NRF2 signalling. The 
model consists of three main subsystems NRF2 signalling (see scheme in Fig. 1): a) the 
cellular antioxidant system; b) KEAP1-dependent degradation/ ubiquitination of NRF2 in the 
cytoplasm; and c) gene regulation of the antioxidant system by NRF2. The model captures 
the following processes as distinct modules: 1) KEAP1-dependent degradation/ 
ubiquitination of NRF2 in the cytoplasm; 2) oxidation of KEAP1 by H2O2  resulting in the 
dissociation of the NRF2-KEAP1 complex and inhibition of NRF2 degradation; 3) diffusion 
of free NRF2 into the nucleus; 4) formation of the activation transcription factor NRF2-MAF 
heterodimer; 5) binding of NRF2-MAF to ARE sites; 6) translation of antioxidant enzymes 
including Trx, Tpx, and Gpx; 7)  formation of the repression transcription factor MAF-MAF 
homodimer and its binding to ARE sites causing repression of NRF2-dependent gene 
transcription; 8) reduction of KEAP1 by Trx; 9) cellular production of H2O2 and its 
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degradation by antioxidant enzymatic system; 10) diffusion of endogenous H2O2 through the 
cellular membrane; 11) catalysis of GSH from endogenous NAC.  
 
The kinetic model of NRF2 signalling comprises of 16 ordinary differential equations 
provided in Supplement1. The model parameters were chosen based on experimental data 
available from literature and results of fitting of the model against our own experimental data 
(Tables S2 and S3 in Supplement I). In the model we have made the following assumptions. 
Oxidation of 2KEAP1-(SH)2 leads to the formation of the KEAP1-SS-KEAP1 bond 
(Wakabayashi et al., 2004) and Trx1 reduces the KEAP1-SS-KEAP1 bond. The KEAP1 
dimer binds to NRF2 molecules resulting in a 2:1 and 2:2 stoichiometry (Lo et al., 2006). 
NRF2 nuclear translocation is assumed to be free diffusion across nuclear membrane and 
KEAP1-independent. We ignored KEAP1-dependent NRF2 nuclear export (Sun et al., 2011). 
 
The complex intracellular antioxidant system that degrades H2O2 was described 
phenomenologicaly in the model (Sokolovski et al., 2013) through the redox-balancing 
cascade reactions corresponding to key antioxidant enzymes, i.e. the thioredoxin peroxidase/ 
thioredoxin/ thioredoxin reductase (Tpx/Trx/TR) and glutathione peroxidase/ glutathione/ 
glutathione reductase (Gpx/GSS/GR) systems (see module 9 in Fig. 1). Instead of specific 
enzymes, we considered the following phenomenological enzymes: Px corresponding to 
peroxidase, Tpx and Gpx; PSH corresponding to GSH and Trx, protein containing thiol 
groups; and Red corresponding to reductases, with TR and GR reducing GSS and Trx. 
Kinetic parameters of these antioxidant enzymes in the model were based on available 
experimental data on Tpx, Trx, and TR enzymes (see Table S2 in Supplement1). The 
concentrations of the phenomenological enzymes (Pr, PSH, and Red) were determined as a 
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result of the fitting of experimental data on the basal level of intracellular H2O2 concentration 
(Qutub and Popel, 2008). In the model we neglected the processes of H2O2 degradation 
through the oxidation of cellular proteins and the generation of free radicals by H2O2. As 
shown in (Adimora et al., 2010) the antioxidant enzyme cascade considered in the model 
plays a major role in maintaining of redox homeostasis and oxidative stress signalling in 
cells.  
  
The model of the NRF2-dependent gene response to oxidative stress was based on the 
following experimental data. In the nucleus NRF2 binds with ARE promoter sites 
predominantly in a complex with small MAF protein initiating the transcription of NRF2-
dependent genes (Yamamoto et al., 2006). We assume that MAF is a nuclear protein which 
ensures accumulation of NRF2 in the nucleus (Li et al., 2008) and the MAF homodimer acts 
as a repressor: its binding with ARE sites causes the repression of NRF2-dependent gene 
transcription (Yamamoto et al., 2006). In the calculation we ignored another repressor of 
ARE sites, BACH1 (Boutten, Goven, Artaud-Macari, Boczkowski, & Bonay, 2011). In the 
model the complexes NRF2-MAF (activator) and MAF-MAF (repressor) control expression 
of genes encoding antioxidant enzymes. The processes of transcription and translation were 
modelled phenomenologically by Eq. (20) (Table S1 in Supplement I) describing Px enzyme 
induction. To obtain the kinetic parameters of the transcription complex formation we used in 
vitro data on binding of NRF2-MAF and MAF-MAF complexes with ARE sites (Yamamoto 
et al., 2006). In the model we took into consideration 10
3
 ARE sites under NRF2 control 
(Chorley et al., 2012) which all have approximately the same affinity to NRF2-MAF and 
MAF-MAF complexes. This assumption is in agreement with the fact that different 
nucleotide alterations in the ARE sequence do not change significantly its affinity to NRF2-
MAF and MAF-MAF complexes (Yamamoto et al., 2006). 
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3. Results 
 
3.1  Ovarian cancer cells show distinct growth rates that correlate with basal ROS 
 
A growing body of evidence has suggested that the multitudes of mutations found in different 
cancerous cells not only cause irregularities and defects in normal cell cycle function, growth 
control and drug resistance, but also metabolic aberrations, oncogenically stimulated ROS 
stress and overall growth advantage (Benhar et al., 2001, Hlavatá et al., 2003). To examine 
the rates of cell proliferation, normal epithelial keratinocytes (HaCaT) and a panel of ovarian 
cancer cell lines (OVCAR3, OVCAR4, PEO1, PEO4, PEO6 and SKOV3) were grown for 6 
days. Cellular growth was monitored by counting the total viable cells daily. All the cell lines 
showed specific rates of proliferation. Differences were also noted for the three isogenic PEO 
cell lines (Fig 2a). Since the previous literature has shown endogenous ROS to induce 
proliferation in a variety of cell lines including ovarian (Ruiz-Ginés et al., 2000, Velarde et 
al., 2004, Hu et al., 2005, Paul et al. 2009), we next determined constitutive intracellular ROS 
levels in our cell line models by performing a general ROS assay (CELLROX
®
, Life 
technologies). This was done in order to assess the correlation of ROS with growth rates. At 
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different days of cell growth, H2O2 levels were also determined (AmplexRed
®
) and 
quantified. We observed a consistent gradual build-up of intracellular H2O2 among all cell 
lines. The intracellular H2O2 production reached maxima by day 2 and remained stable 
thereafter with slight oscillatory fluctuation (Supplement II Fig. 1a). However, there were 
fundamental differences in the constitutive levels of both intracellular general ROS and H2O2 
among the different cell lines. Higher levels of these were generally recorded with the 
cancerous cell lines relative to the normal HaCaT epidermal keratinocytes (Fig 2). 
Furthermore, there was a positive and statistically significant correlation between the 
intracellular total ROS and mean H2O2 levels (r= 0.556, n= 35, p=0.001). The correlation 
between total ROS and H2O2 persisted especially during the exponential phase of cellular 
expansion (r=0.813, n=35, p<0.001, (also see Supplement II Fig. 2b &c).  
 
Mathematical fitting of the experimental growth data suggests a mixture of early exponential 
and late linear expansion pattern among the cell lines in general (Fig 2a). Linear regression of 
the cellular proliferation data, especially in the exponential phase (usually day 1-5), produced 
a mean growth rate constant (µ) range of 0.23 - 0.51 among the cell lines studied (see 
methods). Table 2 lists the calculated growth rates from the proliferation assay, as well as 
ROS and H2O2 levels for all the cell lines studied. We found that while the mean growth rate 
constant for most of the cancer cells was greater than or equal to that of normal (HaCaT) cells 
(i.e. >0.40), lower µ values of 0.28 and 0.23 were recorded with the cancerous PEO4 and 
PEO6 respectively; 2-fold lower than that of their isogenic PEO1 cell line (matched by lower 
ROS values). Analysis of mean growth rates and accompanying ROS revealed that the 
production and maintenance (sequestration) of higher constitutive levels of intracellular ROS, 
in particular H2O2, in cancerous cell lines typically conferred higher and hierarchical growth 
advantage rates (Table 2 and Fig. 2a). Likewise hierarchical growth advantage rates that 
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segregated in line with intracellular ROS and H2O2 levels were observed even among the 
isogenic cancer cell lines PEO1, PEO4 and PEO6 (Supplement II Fig. 2a & b).  
 
For the cancer cells, statistical analysis revealed a significant and positive correlation 
between µ and ROS (r=0.932, n=6, p=<0.05) and a positive but statistically not significant 
correlation with H2O2 (r=0.536, n=7, p=0.215, Supplement II Fig. 2b & c). The normally 
functioning HaCaT cells have a distinct profile, with growth rate in line with the majority of 
cancer cell lines but a reduced ROS level. This initial analysis of these elements of cellular 
behaviour revealed that cellular proliferation may control, or at least influence, stable and 
reo-adjustable dynamic ROS levels in a cell-dependent manner which may feed into 
pathways that in turn impact cellular physiology and growth.  
 
3.2 Cells utilise basal ROS to control NRF2 subcellular compartmentalisation and 
association with KEAP1 
 
ROS stress in cancer cells may exhibit an activated status of antioxidant response signalling 
as an adaptive mechanism to maintain sub lethal levels of ROS but still be sufficient to serve 
as signalling molecules. Consistent with this, previous studies have shown elevated levels of 
basal NRF2 and its substrates in tumours (Lister et al., 2011, Soini et al., 2001). The coupling 
of ROS with cellular proliferation that we found here is indicative of ROS being propagatable 
and transducible messenger molecules throughout the whole cell. This gives rise to variable 
levels of basal cellular redox in different cellular compartments and organelles that 
interconnect with the redox homeostatic regulatory network (Kietzmann, 2010). The NRF2-
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KEAP1 adaptive system is central to the maintenance of this redox balance and may be a 
critical determinant of sensing and coordinating the oxidative stress (ROS) response with 
cellular proliferation (Reddy et al., 2007). To explore this coordinating role, constitutive 
NRF2 and KEAP1 levels and NRF2 localisation in all cell lines were quantified. We first 
used known amounts of recombinant standard NRF2 and KEAP1 proteins to calibrate and 
generate reference standard curves for the absolute determination of the amount of both 
proteins in cells (Supplement II Fig. 3). Immunoblotting for endogenous proteins revealed 
that the cell lines contained highly detectable but dissimilar levels of both NRF2 and KEAP1 
proteins (Fig. 3); cancer cells contained higher levels of total constitutive NRF2 and KEAP1 
proteins than HaCaT cells. Among the cancer cell lines PEO1 exhibited highest levels of 
NRF2 while OVCAR4 showed the lowest. KEAP1 was highest in SKOV3 and lowest in 
OVCAR4. The stability of NRF2 is greatly influenced by the overall redox balance (Niture 
SK et al., 2013). We reasoned that the dissimilar levels of basal NRF2 and KEAP1 levels 
could be linked to the distinct intracellular ROS profiles determined earlier and as such could 
symbolise a consequence of basal ROS balance which in turn represents the metabolic and 
growth status of cells. We observed a statistically significantly correlation of ROS with 
KEAP1 levels (r=0.794, n=7, p<0.05) and a correlation between the total intracellular ROS 
with constitutive total NRF2 (r=0.619, n=7, p=0.137, Supplement II Fig. 4a) for our cell 
lines. Also the mean cellular H2O2 levels correlated significantly with both the constitutive 
total NRF2 (r=0.893, n=7, p = 0.007) and KEAP (r=0.857, n=7, p=0.014) proteins of the cells 
(Supplement II Fig. 4b). Interestingly the total constitutive NRF2 and KEAP1 levels in the 
cells correlated (r=0.692, n=7, p=0.085) albeit not statistically significant at two-tail but 
significant at one-tail test (r= 0.692, n=7, p < 0.04, Supplement II Fig. 4c). Moreover, the 
ratio of constitutive total KEAP1 to NRF2 is conserved across the cancer cell lines (1.5-4.6) 
in comparison with the substantially higher ratio for non-cancerous HaCaT epithelial 
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keratinocyte (7.44, see Table 2). Thus the intracellular ROS levels among these cell lines 
appeared to not only correlate with and perhaps impact the earlier observed hierarchical 
growth rates but also modulate levels of total constitutive NRF2 and KEAP1 expression that 
in turn may maintain the observed growth advantage. Altogether, these results suggest that 
the growth rates of cells are linked with ROS including H2O2 generation and overall redox 
homeostasis, which serves to modulate basal NRF2 and KEAP1 levels and subcellular 
localisation of NRF2.  
 
Previous reports have shown that within the nucleus NRF2 signals in pro-survival pathways 
(Niture et al., 2012a & b, Ohta et al., 2003), triggers proliferation (Homma et al., 2009, 
Zhang et al., 2012) and is implicated in drug resistance (Wang et al., 2008). Similarly, 
knockdown of NRF2 has been reported to curb growth of tumour in vivo and in vitro 
(Manandhar et al., 2010, Singh et al., 2008). We next considered whether the high amount of 
ROS that we observed in cancer cells with enhanced growth rates could induce nuclear 
localisation of NRF2. This could then further feed into survival pathways ensuring a 
persistent growth advantage in cancer cells. Cellular fractionation followed by immunoblot 
analysis of NRF2 protein levels in our panel of ovarian cancer cell lines revealed a 
predominant nuclear localisation in PEO1 (80% of total expressed), PEO4 (>75%), PEO6 
(80%), and SKOV3 (80%) ovarian cancer cell lines. In the non-cancerous HaCaT epidermal 
keratinocytes, NRF2 was mostly cytoplasmic in the basal state (60%). Interestingly the 
OVCAR3 and OVCAR4 ovarian cancer cell lines were found to only contain 20-25% of total 
NRF2 in their nuclei while the remainder is cytoplasmic (Fig. 4a). The quality of cellular 
fractionation was determined by blotting for nuclear and cytoplasmic marker proteins 
(Supplement II Fig. 5a). Thus, the degree of nuclear retention of NRF2 and the overall ratio 
of nuclear to cytoplasmic distribution was similar in the three PEO cell lines and quite 
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distinct from the OVCAR 3 & 4 and non cancerous HaCaT cell lines. In order to study the 
subcellular localisation of NRF2 at single cell level, we performed immunofluorescent 
labelling of NRF2 and confirmed the mostly nuclear localisation in PEO1, PEO4, PEO6 and 
SKOV-3 cells, in contrast to the predominantly cytoplasmic expression in OVCAR3, 
OVCAR4 and HaCaT cell lines (Fig. 4b). Association of NRF2 with KEAP1 was represented 
as merged images of immuno labelled NRF2 and actin staining followed by analysing their 
colocalisation (Fig. 4b, lower panels).  
 
Based on these results we observe 3 major groups stratified on the basis of NRF2 localisation, 
ROS and growth rates: (1) HaCaT with average growth rate, lower ROS and mostly 
cytoplasmic NRF2; (2) SKOV3, PEO1, PE04 and PEO6 with average to high growth rate and 
average to high ROS and mostly showing nuclear localisation of NRF2; (3) OVCAR3 and 
OVCAR4 with average to high growth rate and average to high ROS and exhibiting low 
levels of nuclear NRF2. This grouping suggests differential cellular mechanism(s) for the use 
of the NRF2-KEAP1 status and compartmentalisation to control ROS redox balance in cells 
and to confer and regulate cellular proliferative capacity.  
 
3.4 NRF2 localisation and stability are linked to ROS sequestration and maintenance 
potential 
 
We next determined whether the observed variation in terms of proliferation and basal ROS 
with the accompanying adaption of distinct subcellular localisation pattern of NRF2 in 
different cell lines would result in differences in NRF2 protein stability. If indeed these 
23 
 
factors influence NRF2 stability this would cause differences in the kinetics and half-life of 
NRF2 and could further confirm the link of NRF2-KEAP1 dynamics to the control of ROS 
homeostasis and cellular proliferative capacity. Thus the relationships between the basal 
NRF2 protein turnover (half-life), the basal ROS levels, the NRF2 localisation, and the 
proliferative capacity of the cells were assessed. First, the stability of NRF2 in exponentially 
growing cells following the inhibition of protein synthesis by cycloheximide chase assay was 
examined. Subsequent immunoblotting for NRF2 at different time points post cycloheximide 
treatment and the mathematical fitting of the experimental data by an exponential model of 
NRF2 degradation interestingly revealed differences in the stability and half-life of the 
protein among the cell lines examined (Fig. 5a & 5b, for loading control see Supplement II 
Fig. 5b). Time-dependent degradation of NRF2 exhibited biphasic kinetics, requiring fitting 
experimental curves by two-exponential equations (see Methods) to characterise two distinct 
phases of degradation: ‘fast’ and ‘slow’. The half-life parameters corresponding to fast and 
slow degradation, Tfast,NRF2 and  Tslow,NRF2 respectively are given in Table 2 and the best-
fitting curves are depicted in Figure 5b. The fastest degradation of NRF2 protein was 
recorded with the non-cancerous HaCaT keratinocyte with estimated 30 s of fast and 24 min 
of slow turnovers of NRF2 (Fig. 5a & b, Table 2). The cancer cell lines have much more 
stable NRF2 levels and attenuated fast (25-75 fold slower) and slow (2-13 fold slower) 
degradation kinetics, as well as with much longer overall half-life (2-5 fold longer) when 
compared to HaCaT. Thus both inter and intra differences in the degradation kinetics of 
NRF2 among the HaCaT and various ovarian cancer cell lines appeared to support the earlier 
observed hierarchical segregation and clustering of the studied cells into 3 major groupings 
informed by key elements of cellular antioxidant pathway and growth behaviours.  
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However, we could not find any relation between basal NRF2 or KEAP1 levels and 
degradation kinetics. Given the earlier significant correlation between H2O2 and both NRF2 
and KEAP1, the influence of H2O2 levels on the degradation kinetics of NRF2 was examined. 
The mean H2O2 levels were found to positively and significantly correlate with the fast 
degradation kinetics (r=0.679, n=7, p=0.047) and half-life (r=0.703, n=7, p=0.039) of NRF2 
albeit at one-tailed level, but not with the model generated slow degradation kinetics 
(r=0.643, n=7, p=0.06, see Supplement II Fig. 6a & b). This correlation suggested that cells 
carrying higher basal H2O2 levels have greater NRF2 stability, which is consistent with the 
classical model of NRF2 regulation. While basal NRF2, KEAP1 and ROS levels together 
with growth rate (μ) did not correlate with the half-life of NRF2, KEAP:NRF2 ratio did 
however exhibit inverse correlation (r=-0.879, n=7, p<0.05, see Supplement II Fig. 6c). These 
findings suggest that general cellular ROS levels, in particular H2O2, have direct effect on 
basal NRF2 and KEAP1 protein levels, which in return control and maintain redox balance. 
Cell specific alterations of these factors seem to influence the basal protein stability of NRF2 
and may determine overall redox potential in a tissue specific manner.  
 
3.5 Distinct cellular response of cancer cells to redox perturbation is explained by dynamics 
of NRF2 nucleocytoplasmic shuttling and compartmentalisation 
 
It is conceivable that ROS (including H2O2), redox balance in cells and the NRF2-KEAP1 
dynamics are intricately linked and influenced by cellular ROS production and sequestration 
potentials. We hypothesised that the distinctive constitutive ROS maintained by cells might 
be as a result of their varying proliferative and metabolomic profiles, which would 
subsequently affect nuclear localisation and retention of NRF2. Once in the nucleus, NRF2 
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would be more stable, and this stability would ultimately influence its half-life to inform its 
antioxidant function as well as signal back into proliferative pathways. Our hypothesis was 
that based on basal redox profile, different cells may react with different kinetics to the same 
level of exogenous sources of pro- and antioxidants. Specifically, cells with higher ROS or 
pre-existing nuclear NRF2 might represent a readily active antioxidant system and may 
robustly remove exogenous oxidative radicals with faster kinetics. To test this, we 
exogenously added 5 µM H2O2 to the cells followed by assaying for H2O2 levels in the media 
over time. This allowed us to assay for cellular antioxidant potential based on kinetics of 
H2O2 removal. 
 
First of all, we found that the antioxidant pathway is rapidly activated following oxidative 
challenge in all our cell lines as robust scavenging and fast H2O2 reduction kinetics was 
observed (Fig. 6). Secondly, the reduction of H2O2 followed an damping oscillatory pattern 
which could be indicative of engagement of feedback loops. Thirdly, we found distinct 
differences in the kinetics of reduction of H2O2 signal overtime. PE04 demonstrated most 
efficient reduction and sequestration capacity with only 10% H2O2 relative to time 0 
remaining after 10 min. PE04 and PE06 had similar levels of H2O2 after 20 minutes; 
OVCAR3 showed a similar profile. SKOV3 cell line, which was found to have the highest 
basal ROS neutralised exogenous H2O2 only minimally to restore its higher basal levels. 
Interestingly, although HaCaT cell line had the lowest basal ROS, it still failed to neutralise 
external H2O2 as efficiently and fast as its PEO or OVCAR counterparts. Thus all cells treated 
with 5 μM H2O2 revealed a robust but cell specific time-dependent H2O2 scavenging abilities 
and reducing kinetics of cells, which is likely informed by the cellular dynamics of the NRF2 
antioxidant signalling response. Altogether, this further strengthened the assumption that cells 
with different growth rates, basal ROS and NRF2 stability have different efficiencies of their 
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antioxidant system. Moreover, the fact that addition of external ROS in cancer cells was 
quickly neutralised to the level of their corresponding basal ROS (but not in normal cell line) 
demonstrated cancer cell’s addiction to a specific higher level of basal ROS.  
 
Sub-cellular protein trafficking and localisational control of NRF2 is a key element in the 
regulation of NRF2 mediated antioxidant response (Jain AK et al., 2005, Theodore M et al., 
2008). The localisational control and compartmentalisation of NRF2 has also been linked to 
its protein stability (Itoh K et al., 2003, Niture SK et al., 2011), a key element that we found 
to be different in our cell line models. Hence, to extend our line of investigation, we next 
perturbed the redox balance within the cells and in parallel, studied its effects on NRF2 
localisation in cell dependent manner. This was also done to identify whether the differential 
kinetics of H2O2 scavenging assay could be related with NRF2 trafficking and localisation 
dynamic following pro-oxidant challenge.  Using HaCaT, PEO1 and OVCAR3 cell lines to 
represent and exemplify the 3 clustered groups, perturbation of basal cellular redox 
homeostasis was done by exogenous oxidation or reduction of the cellular environment with 
100 μM H2O2 a pro oxidant or 10 mM N-Acetyl Cysteine (NAC), a well-known ROS 
scavenger, respectively for different time points as indicated.  
 
To demonstrate that our treatment regimes chosen indeed altered cellular ROS, cells were 
subjected to time course treatments of the above pro and antioxidants and assayed for cellular 
ROS content (Supplement II Fig. 7).  Immunofluorescent labelling of NRF2 was carried out 
in the three cell lines using the NRF2 primary antibody (Santacruz, UK) and an Alexa fluor 
488 conjugated anti rabbit secondary antibody (Invitrogen, UK) to label endogenous NRF2 
(Green fluorescence). DAPI staining (Vectasheild labs) was performed on the same cells to 
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stain nuclear DNA and provide for nuclear reference (Blue fluorescence). As previous studies 
have reported that the cytoplasmic KEAP1 is localised at the Actin filaments (Kang et al., 
2004), we also performed actin staining (red fluorescence) to indicate cytoplasmic 
localisation of NRF2 in KEAP1 bound state (Red fluorescence). Merging was performed 
between the images captured in different channels to indicate and differentiate nuclear NRF2 
and extra nuclear cytoplasmic NRF2. Whole cell, nuclear and cytoplasmic fluorescent 
intensities were individually measured and quantified with the intensity of untreated cells 
(UT) set as 100% (Fig. 7).  
 
We found that generally there was gradual reduction or increase in total NRF2 levels in the 
cells following treatment with NAC or H2O2 respectively (Fig. 7b, e & h). NAC treatment 
caused reduction in nuclear fluorescence of NRF2 with a corresponding transient 
accumulation in cytoplasm. However, extension of the treatment time reduced the 
cytoplasmic fluorescence of NRF2 with an overall decrease in total fluorescence indicating 
degradation in the cytoplasm (Fig. 7c, f & g). In contrast, H2O2 treatment caused nuclear 
accumulation of NRF2 with a corresponding reduction in cytoplasmic fluorescence indicating 
nuclear trafficking and increased total intensity exhibiting an overall increase in protein 
levels.  We found that the dynamics of such nuclear-cytoplasmic shuttling as well as overall 
total changes in NRF2 expression following treatments were different among the cell lines 
examined. It is interesting to note that while the overall kinetics of NRF2 induction following 
H2O2 was similar, there was a faster nuclear accumulation of NRF2 in PEO1 and OVCAR3 
as compared to HaCaT (compare Fig. 7 c and i with f). This is consistent with our H2O2 
reduction assay where faster removal of H2O2 was noted for these cell lines as compared to 
HaCaT. Furthermore, this study also supported our earlier assumption that higher nuclear 
NRF2 in cancer cell lines e.g. PEO1 (Fig. 3) might be maintained because of high 
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constitutive ROS (Fig. 2) as neutralisation of the basal ROS reduced nuclear NRF2 in all cell 
lines examined (Fig. 7a, d & g). Thus, it is suggested that while cell specific proliferation 
rates maintain a basal level of ROS, this redox status in turn influences the constitutive and 
induced NRF2 activity. All these elements of growth and signalling converge together to 
inform the redox potential of a cell and determine overall antioxidant efficiency and capacity 
(Fig. 6). The quantitative immunofluorescence data generated in these experiments was used 
to further parameterise our NRF2 dependent in silico model of antioxidant pathway and we 
report on model findings below.  
 
3.6 Cancer cells are addicted to elevated levels of basal ROS 
 
One of the assumptions made in our study is that the different levels of basal ROS established 
across cell lines is due to their distinct growth rates and that cancer cells might be addicted to 
such elevated ROS (see earlier correlation of ROS and growth rate for cancer cells). The role 
of physiological ROS as a signalling molecule in key signalling pathways (D'Autréaux B et 
al., 2007) including proliferation (Ruiz-Ginés et al., 2000, Valarde et al., 2004, Lister et al., 
2011, Wang et al., 2013) has been shown in a number of studies. In order to illustrate that 
physiological ROS might be involved in maintaining high growth rates, a cellular 
proliferation assay was performed in the presence of 10 mM NAC. Moreover, to study the 
degree of resistance of cells to exogenous ROS, proliferation was also performed in the 
presence of 20 µM H2O2. Again, the HaCaT, PEO1 and OVCAR3 cell lines were used to 
represent the 3 different clusters of cellular behaviours identified earlier. 
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As expected, we found different sensitivities of the three cell lines to the treatments. 
Treatment of the cells with H2O2 was most inhibitory to cell growth in the HaCaT cell line 
followed by OVCAR3 cells (Fig. 8). PEO1 cell line was found to be minimally inhibited by 
H2O2 treatment. Interestingly, neutralisation of basal ROS through NAC treatment 
substantially inhibited the proliferation of the two cancer cell lines and overall slowed the 
growth rates. This validates our earlier assumption that cancer cells might be addicted to 
elevated levels of ROS that may feed into proliferative pathways and maintain a high growth 
rate, e.g. OVCAR3 with a higher basal ROS was more sensitive to NAC than PEO1 with 
slightly lower basal ROS (compare Fig. 2 & 8). However, in HaCaT cells, NAC 
paradoxically increased the proliferation rate indicating that this addiction to ROS might 
specifically be an ovarian cancer cell phenomenon. Overall, the two ovarian cancer cell lines 
were more resistant to redox perturbation. Linear regression of the proliferation data and 
following these treatments produced similar results (Supplement II Fig. 8). Interestingly the 
inhibitory effect of NAC on the growth of the cancer cell lines was greatest with OVCAR3 
and OVCAR4 and moderate with SKOV3 and PEO6 (data not shown). Thus ROS scavenging 
with the antioxidant NAC slows down the proliferation of ovarian cancer cells hierarchically, 
but not in normal epithelial keratinocytes. These experiments revealed that the proliferation 
of these cells was dependent on basal constitutive ROS levels. Furthermore, enhanced 
hierarchical pro-oxidant scavenging or sequestration capacity was observed among the cancer 
cell lines and appeared to be compromised or attenuated in normal HaCaT keratinocytes.  
 
3.7 Modelling NRF2-KEAP1 dependent redox regulation 
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We used the kinetic model of NRF2 signalling to investigate the mechanism of 
NRF2-KEAP1 dependent redox regulation in different cells in a resting condition and in 
response to oxidative stress. First we modelled a basal level of H2O2 corresponding to redox 
homeostasis in proliferating cells. The model reproduces the experimental steady state 
concentration of H2O2 (0.5 μM), which was observed to be in the range of 0.5 μM to 1 μM for 
the different cells under investigation (Table 2). 
 
Modelling of the regulation of redox homeostasis in the cells under oxidative stress 
was carried out on the basis of the experimental data of degradation kinetics for extracellular 
H2O2 measured in the different cells (Fig. 6).   The results of the modelling of degradation 
kinetics following external 5 μM H2O2 are shown in Figure 9. The model reproduced the non-
exponential degradation kinetics of H2O2, characterized by fast decay of H2O2 with half-life 
Tfast,H2O2=5 min, followed by slow degradation to the basal level of H2O2. The modelling 
showed that external 5 μM H2O2 induces an increase in the intracellular level of H2O2 during 
Tfas,H2O2 followed by its fast recovery to the basal H2O2 concentration due to antioxidant 
cellular systems. Extra intracellular H2O2 degrades through the cascade of oxidation/reduction 
reactions of the enzymes involving in ROS cellular scavenging systems (module 9, Fig. 1). 
The model reproduced the typical kinetics of peroxidase oxidised during treatment cells by 
H2O2 (Adimora et al., 2010) (blue line, Fig. 9). The total concentration of peroxidase (Px) in 
the model increased, and this indicates a NRF2-KEAP1-dependent expression of peroxidase 
in response to redox perturbation (red line, Fig. 9).  The switching on of the Nrf2-KEAP1 
dependent genetic regulation causes maximum production of peroxidase enzymes at 1 hour 
after H2O2 treatment and the subsequent slow switching off of the genetic regulation occurs 
following attainment of a basal level of H2O2. 
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To analyse the NRF2-KEAP1-dependent mechanism of genetic regulation of the 
antioxidant enzymes we first described the steady state of NRF2, determined by a KEAP1-
dependent mechanism of NRF2 degradation in the cytoplasm (module 1, Fig. 1). The kinetic 
characteristics of this mechanism were obtained from our NRF2 degradation experiments 
following CHX treatment: CHX action was modelled by setting a zero value for the reaction 
rate of NRF2 expression. Fig. 10 shows the model reproduced the experimental data for Nrf2 
degradation (black lines and points respectively in Figs.10a and 10b). The modelled half-life 
for fast degradation Tfast,Nrf2=30 s for HaCaT and Tfast,Nrf2=10 min for PE01 cells was in 
accordance with our experimental data (Table 2).  We then calculated separately the 
degradation kinetics of NRF2 in the cytoplasm and the nucleus (Figs. 10a and 10b, red and 
blue lines respectively). The fast kinetics of NRF2 degradation is due to NRF2 degradation in 
the cytoplasm through a KEAP1-dependent mechanism. According to the model, the slow 
kinetics of NRF2 degradation is defined by the slow release of NRF2 from the nucleus 
(module 3, Fig. 1) followed by its degradation in the cytoplasm through a KEAP1-dependent 
mechanism. The contribution of these fast and slow processes to the total degradation kinetics 
depends on the fraction of cytoplasmic and nuclear NRF2 in the cells: a prevalence of slow 
kinetics is attributed to cells with a high fraction of the basal nuclear NRF2 level. In the 
calculation, the ratio of the steady state concentrations of cytoplasmic to nuclear NRF2 was 
50:50 and 20:80 for HaCaT and PEO1cells respectively (see initial point at t=0 in Figs. 10a 
and 10b) which correspond to our experimental data (Table 2). The different distribution of 
NRF2 between cytoplasm and nucleus in the model for HaCaT and PEO1 cells is defined by 
different H2O2 levels in these cells: 490 nM and 630 nM respectively (Table 2). A higher 
level of H2O2 in PEO1cells defines a higher nuclear concentration of NRF2 in PEO1cells in 
comparison with HaCaT cells. 
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To analyse the kinetics of the NRF2 redistribution between the cytoplasmic and 
nuclear compartments in response to redox perturbation we modelled NRF2 kinetics during 
oxidation and reduction in the intracellular environment by cell treatment with 100 mM H2O2 
and 10 mM NAC, respectively (see Fig. 7). In line with experimental data, modelling showed 
that extra H2O2 causes an increase in total NRF2 (black points and lines in Fig. 11a) that 
occurs due to the suppression of KEAP1-dependent degradation of NRF2 as a result of 
KEAP1 oxidation. Increasing total NRF2 increases passive transport of NRF2 to the nucleus 
and its subsequent accumulation due to binding with nuclear protein MAF (blue lines and 
points in Fig. 11a).  In the model the cytoplasmic concentration of NRF2 changed slightly; in 
experimental data a slight decrease is shown (red lines and points respectively in Fig. 11a). 
We suggest that this faster trafficking of NRF2 from cytoplasm to nucleus may result from 
active transport of NRF2 through the nuclear membrane in additional to the passive diffusion 
in the model (Boutten et al., 2011). 
 
In silico modelling of the reduction in the intracellular environment by NAC showed 
opposing NRF2 kinetics to those observed in the cell oxidation experiment (Fig. 4). The 
model describes satisfactorily decreases in total, nuclear and cytoplasmic NRF2 
concentrations as a result of the reduction in the intracellular environment (black, blue and 
red lines and experimental points respectively in Fig. 11b). The decrease in total NRF2 is due 
to a reduction in KEAP1 by thioredoxin and the formation of KEAP1-NRF2 complexes in the 
cytoplasm followed by the degradation of NRF2 in the cytoplasm. A decrease in cytoplasmic 
NRF2 leads to a diffusion of NRF2 from nucleus effected by a decreasing nuclear 
concentration of NRF2 and a switching off of expression of NRF2-dependent genes. 
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The KEAP1-NRF2-dependent regulation mechanism in the model reflects different 
perturbations to redox homeostasis and includes the following interconnected processes: 
KEAP1 oxidation/reduction; KEAP1-dependent mechanism of NRF2 degradation; nuclear to 
cytoplasmic shuttling of NRF2; and NRF2 induced formation of a transcription factor leading 
to transcription of genes encoding antioxidative enzymes. The gene regulation by nuclear 
NRF2 forms a negative feedback: an increase of nuclear NRF2 causes expression of 
antioxidative enzymes that in turn cause a decrease in total and nuclear NRF2 concentrations 
due to reduction of an oxidized form of KEAP1 (module 8, Fig. 1). To analyse the role of this 
negative feedback in the whole regulatory mechanism we calculated the regulation curve of 
this system, i.e. the dependence of the control parameter, NRF2 level, on the controlled 
parameter, steady state concentration of H2O2 (Fig. 12). This NRF2-H2O2 regulation curve 
shows an S-type characteristic and defines the mutual dependence between NRF2 and H2O2 
concentrations in cells: H2O2 level defines NRF2 concentration in the nucleus; in turn NRF2 
controls H2O2 in cells. 
 
Analysis of this control loop based on the NRF2-H2O2 regulation curve allows 
tracking of the dynamics when moving from low to high endogenous concentrations of H2O2. 
An increasing level of endogenous H2O2 in the model was obtained by increasing the rate of 
H2O2 synthesis (VH2O2prod) in cells. An increase in H2O2 in the range of 100 nM – 700 nM 
causes a gradual growth of NRF2 concentration due to a slowing down of KEAP1-dependent 
degradation of NRF2 as a result of KEAP1 oxidation. In this region of H2O2 concentration, a 
basal level of antioxidative enzymes in the cells is enough to maintain a steady state of H2O2 
in the range up to 700 nM, shown in Fig. 12 on the forward branch of the curve from the 
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origin up to the sharp change in direction. A further increase in the rate of H2O2 synthesis 
causes fast growth of both total and nuclear NRF2 concentrations that induces the NRF2-
dependent genetic response of the cells to high level of H2O2: an increasing level of 
transcription factor NRF2 in the nucleus causes expression of antioxidative enzyme 
peroxidase (Px) in the model (module 6, Fig. 1). In turn, an increasing level of Px leads to a 
decreasing H2O2 concentration that corresponds to the reverse branch on the S-type regulation 
curve in Fig. 12. Note the reverse branch of the S-type regulation curve is stable: cells can 
have NRF2 and H2O2 concentrations situated on this branch. There is an inverse dependence 
between the controlling parameter, NRF2 level, and controlled parameter, level of H2O2, on 
this reverse branch of the NRF2-H2O2 regulation curve opposed to a direct dependence on the 
forward branch. At a still higher rate of H2O2 synthesis a saturated level of total and nuclear 
NRF2 (80%) is attained at which the expression of NRF2-dependent genes proceeds at a 
maximum rate. The saturated level of NRF2 is defined as a mainly nuclear concentration of 
MAF and cytoplasm/nucleus equilibrium of free NRF2. The characteristic of the NRF2-H2O2 
regulation curve at higher rates of H2O2 synthesis alters significantly: the reverse branch 
changes to a saturated branch. On this saturated branch, the further increase of VH2O2prod leads 
to an increase of a steady state concentration of H2O2 which is maintained by the maximum 
expression rate of antioxidant enzymes. On this saturated branch a regulatory role of NRF2 is 
in maintaining the maximum expression rate of antioxidant enzymes to support high level of 
steady state concentration of H2O2.  
 
To validate this model behaviour we compared the NRF2-H2O2 regulation curve with 
the measurements of total and nuclear NRF2 levels and endogenous H2O2 concentration 
obtained in our experiments for the seven cell lines (see points, Fig. 12 taken from Table 2). 
The theoretical regulation curve qualitatively describes a complex NRF2-H2O2 relationship in 
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the different cells. NRF2 and H2O2 concentrations in HaCaT and OVCAR4 cells are located 
in the vicinity of the forward branch of the regulation curve where there is a direct 
dependence of total and nuclear NRF2 concentration on H2O2 concentration. NRF2 and H2O2 
concentrations in PEO4 cells, having lower H2O2 and higher NRF2 levels than OVCAR4 
cells, lie near the reverse branch of the regulation curve where NRF2 regulation leads to an 
inverse dependence between NRF2 and H2O2 concentrations.  NRF2 and H2O2 concentrations 
for PE04, PE01, OVCAR3, and SKOV3 cells lie in the range of the saturated branch of the 
regulation curve where maximum total and nuclear concentration of NRF2 do not change 
when H2O2 level increases. Although PE01 total and nuclear NRF2 concentrations lie much 
higher than those defined by the saturated branch we assume that PE01 cells relate to the 
saturated branch of the regulation curve because of maximum fraction of nuclear NRF2 
(83%) in this cell line. This deviation may be due to the fact that the NRF2-H2O2 regulation 
curve was calculated for “a reference cell” with parameters being independent of the features 
of different cell lines (see Supplement I).  
4. Discussion 
 
ROS generation is an inevitable outcome of cellular metabolism in all mammalian cells. ROS 
have been implicated in numerous normal and disease cellular processes including 
proliferation, differentiation (Choe et al., 2012; Ho et al., 2013) cell death (Gao et al., 2013, 
ageing and carcinogenesis (Diehn et al., 2009; Hempel et al., 2009; Liu et al., 2012; Okoh et 
al., 2013). The apparent paradox between the positive role of ROS as a cellular signalling 
molecules and its negative role as a cellular intoxicant appears to be highly dependent on the 
production, management and resolution of its intracellular concentration. Answering key 
questions including how mammalian cells precisely coordinate, handle and manage ROS 
levels to inform and execute particular processes will shed light on this paradox. While ROS 
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and antioxidant enzyme defenses have been studied in many tumours (Chaiswing et al., 2011; 
Laurent et al., 2005), the role of these important molecular species in ovarian cancer has not 
been examined in detail. Here, we used experimentally derived quantitative data to define 
several key components that control the redox characteristics of ovarian cancer cells and 
determine the role of oxidative stress on the addiction of ovarian cancer cells to ROS, which 
might confer and maintain cellular proliferation advantage.  
 
We first determined proliferation characteristics of normal epithelial keratinocytes (HaCaT) 
and a panel of ovarian (OVCAR3, OVCAR4, PEO1, PEO4, PEO6 and SKOV3) cancer cell 
lines under basal redox homeostasis and evaluated the dynamics of ROS production and 
sequestration capacity. It appeared that H2O2 controls or at least impacts on stable and steady 
dynamic levels of ROS in a cell-dependent manner to inform cellular proliferation. We found 
a positive correlation between cellular total ROS, H2O2 and growth rate. Cell proliferation 
could be altered by perturbing the basal redox homeostasis using exogenous H2O2 and the 
antioxidant NAC. It is evident that the production and maintenance of higher constitutive 
levels of intracellular H2O2 in ovarian cancer cell lines conferred higher and hierarchical 
growth advantage rate, even among isogenic cancer cell lines (PEO1, PEO4 and PEO6). This 
is consistent with the literature regarding other cells and cancer types (Ngô et al., 2009; 
Chaiswing et al., 2011), although the manner by which this potential is achieved varies 
widely.  
 
Next, we sought to identify a general net integrative switchable and adjustable sensing, 
filtering, transducer and effector system that may reasonably connect intracellular ROS, in 
particular H2O2, with proliferation in ovarian cancer cells. We hypothesised that the NRF2-
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centred system is a key redox interconnectivity node and interface between ROS, 
cytoprotection and the regulation of proliferation in ovarian cancer cells. Accordingly we 
quantified and evaluated the levels of both NRF2 and KEAP1 in these cell lines, as well as 
the stability and localisation of NRF2. Interestingly, the observed hierarchical growth 
advantage rates among these cell lines appeared to be informed by not only the intracellular 
ROS levels but also by the total constitutive NRF2 and KEAP1 status. Our findings suggest 
that general cellular ROS levels, in particular H2O2, modulate basal cellular NRF2 and 
KEAP1 protein levels. 
 
We observed differences among the different cells in the sub-cellular localisation of NRF2 
and considered whether the observed variation in terms of proliferation, basal ROS, altered 
NRF2 protein levels and/or its nuclear localisation also results in enhanced NRF2 protein 
stability. Any increased NRF2 stability would cause differences in the kinetics and half-life 
of NRF2 and could further support the links among NRF2-KEAP1 dynamics, control of ROS 
homeostasis and proliferative capacity. Modelling and analysis of NRF2 degradation revealed 
differences in the stability and half-life of the protein among the cell lines. These differences 
suggest there are different cellular mechanism(s) governing NRF2-KEAP1 dynamics, status 
and compartmentalisation to control the ROS redox balance in cells. Mathematical fitting and 
modelling of NRF2 degradation data showed the time-dependent degradation of NRF2 to be 
biphasic, consisting of fast and slow degradation stages. The fastest degradation was recorded 
in HaCaT cells: estimated fast (30 s) and slow (24 min) turnovers of NRF2 with an overall 
half-life of approximately 5 min. In contrast, NRF2 is much more stable in cancer cell lines: 
the fast and slow phases were 25-75 fold and 2-13 fold slower than for HaCaT and the NRF2 
half-life was 2-5 fold longer. The fast degradation kinetic is explained by the classical and 
predominant cytoplasmic NRF-KEAP1-CUL3-dependent degradation mechanism (Baird et 
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al., 2013; McMahon et al., 2004). The slow degradation kinetic may represent the GSK-β and 
the βTRCP dependent mechanism of NRF2 destruction (Chowdhry et al 2013) or the 
KPNA6-KEAP1-dependent nuclear shuttling and export of NRF2 for presentation to CUL3 
and subsequent degradation in the cytoplasm (Sun et al., 2011). It is also conceivable that the 
slow degradation kinetic is explained by a yet to be determined mechanism of NRF2 
degradation in the nucleus as is the case with other transcription factors or nuclear localised 
proteins (Cohen et al 2013; Song et al., 2011).  
 
To confirm that the variation in nuclear localisation among different cell lines is caused by 
basal levels of ROS being maintained to support proliferation in cancer cells, cells were 
treated with either N-Acetyl cysteine or H2O2 to perturb the basal redox homeostasis.  While 
N-Acetyl cysteine caused cytoplasmic sequestration of NRF2 with a concomitant decrease in 
its nuclear accumulation, H2O2 showed a contrary effect. All cells when treated with H2O2 
showed a robust but differential antioxidant signalling response as they scavenge and 
sequester H2O2 in a time dependent manner. The cells also showed remarkable differences in 
the kinetics of signal reduction that in most cases correlated well with the half-life of NRF2 
and NRF2:KEAP1 ratio. Overall the dynamics of the nuclear-cytoplasmic shuttling as well as 
overall total changes in NRF2 expression following the treatments were different among the 
cell lines examined. Interestingly, neutralisation of basal ROS through NAC treatment 
substantially inhibited the proliferation of cancer cell lines by reducing growth rates. On the 
contrary, NAC increased the proliferation rate of HaCaT cells. However, cancer cells 
appeared to resist the growth inhibitory effect of H2O2 better than normal cell line. This 
validates our earlier assumption that cancer cells might be addicted to elevated levels of ROS 
that may feed into proliferative pathways to maintain a high growth rate. This addiction is 
then in addition to the implicated role of ROS in promoting the acquisition of stemness and 
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metastatic phenotypes in cancers (Alexis, et al.; Shimojo etal., 2013; Raha et al., 2014). 
However, it is pertinent to mention that NAC has been shown to promote the proliferation of 
prostate cancer cells (Erin et al., 2012) 
 
To more fully understand cellular responses to these different experimental 
perturbations to redox homeostasis we constructed a model of intracellular signalling that 
represents key response mechanisms to oxidative stress. We profiled the degradation kinetics 
of intracellular H2O2 following the addition of external 5 μM H2O2 and determined that 
cellular response was governed by a NRF2-KEAP1 dependent mechanism. This mechanism 
depended on the dynamic allocation of NRF2 between the cytoplasm and the nucleus and we 
obtained good agreement between the model and experimental data following oxidant and 
antioxidant perturbations (Fig. 11).   We then proposed that the dynamics of NRF2-H2O2 
regulation defines a relationship between total and nuclear NRF2 level and endogenous H2O2 
in various cell lines. 
 
The model predicted different redox states of cells, characterized by the controlling 
parameters, NRF2 concentration, and the controlled parameters, a steady state of H2O2. At a 
low rate of H2O2 synthesis in the cells, the basal concentrations of H2O2 and NRF2 lie on the 
forward branch of the NRF2-H2O2 regulation curve in Figure 12. When the rate of H2O2 
synthesis is increased, the basal concentrations of H2O2 and NRF2 can lie on forward, reverse 
or saturated branches of the regulation curve. In this region of the H2O2 synthesis rate there is 
a steep inverse dependence between NRF2 and H2O2 levels, and concentration of H2O2 is in a 
narrow range of 500 nM – 700 nM while NRF2 concentration can vary significantly. If the 
rate of H2O2 synthesis increases further in the cells, the steady state of H2O2 and NRF2 can 
40 
 
lie only on the saturated branch of the regulation curve with various concentrations of H2O2 
and a constant maximum nuclear NRF2 level. It is likely that the individual NRF2-H2O2 
regulation curve of each cell line or a specific group of cell lines differs. As our analysis 
showed, the regulation curve particularly depends on the KEAP1 and MAF concentrations, 
and these vary in different cell lines (e.g. see KEAP variation in Table 2). Nevertheless the 
present calculation of the reference NRF2-H2O2 regulation curve shows a complex behaviour 
with direct and inverse dependencies between NRF2 and H2O2 levels in cells that in turn 
define a complex relationship between endogenous NRF2 and H2O2 concentrations in cells. 
Note the regulation curve has the S-type feature in the range of high concentration of H2O2 
which corresponds to H2O2 concentrations in the cancer cells investigated in our work. Fast 
dynamic redox regulation in this region of the S-type regulation curve is likely to allow 
cancer cells to maintain high level of endogenous ROS and overcome oxidative stress. 
 
Our findings show that ROS, H2O2, NRF2 status and localisation are intricately linked. The 
observed connection between the ROS and NRF2 pathways might provide a basis for the 
cellular specificity of differential proliferative potentials and behaviours. This connection is 
supported by the use of experimental data, in conjunction with experimental data regarding 
oxidative stress responses and the NRF2-KEAP1 pathway by others (Chorley et al., 2012; 
Malhotra et al 2010; Yamamoto et al., 2006) to mathematically model oxidative stress. The 
model takes into consideration the major components that interdependently feed in and out of 
the NRF2-centred network to sequester or produce ROS. This minimal integrative model of 
cellular oxidative stress responses due to ROS may perhaps inform proliferation behaviour 
and its reconciliation with existing knowledge of the NRF2 signalling system. Our 
experimental results indicate that cells subjected to oxidative signals are directed to execute 
cellular processes such as proliferation up to a critical threshold. This is consistent and in 
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agreement with other experimental findings (Alexis, et al., 2005; Erin et al., 2012). The 
kinetic model allowed us to analyse the contribution of a negative feedback transcriptional 
regulation of the antioxidative enzyme defense systems by the NRF2-KEAP1 response 
signalling.  This suggestion is further strengthened by the observation that NRF2 can auto-
regulate its transcription (Kwak et al., 2002) and that the transcriptional level of the NRF2 
gene acts as another important regulatory point to define cellular NRF2 levels (Suzuki et al., 
2013). 
 
While we are not able to explain all aspects of the observed cellular responses to ROS the 
combined experimental and theoretical systems do shed light on critical features of the 
antioxidant pathway and the mechanisms of ovarian cancer cell adaptation to ROS. This 
systems biology approach provides a useful framework to better understand the role of ROS 
in oxidative stress and in influencing the proliferative behaviour of cells, and potentially other 
cell behaviours. Taking into cognisance the existing gaps, future refinements to this approach 
could lead to a tool to evaluate, predict and manage ROS and so inform therapeutic strategies. 
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FIGURE Legends: 
 
Figure 1: Model of NRF2 signalling which involves the following processes:  (1) KEAP1-
dependent degradation of NRF2 in cytoplasm; (2) oxidation of KEAP1 by H2O2 resulting in 
dissociation of NRF2-KEAP1 complex; (3) NRF2 trafficking into nucleus; (4) formation of 
activation transcription factor, NRF2-MAF heterodimer; (5 and 6) binding of transcription 
factor NRF2-MAF with ARE sites and translation of antioxidant proteins Px; (7)  formation 
of the repression transcription factor, MAF-MAF homodimer, and its binding with ARE sites; 
(8) reduction of KEAP1 by Trx; (9) redox antioxidative enzymatic system degrading H2O2; 
(10) diffusion of H2O2 through cellular membrane; (11) catalysis of GSH from endogenous 
NAC.  
 
Figure 2: Ovarian cancer cell lines exhibit different rates of proliferation that show 
agreement with constitutive ROS levels. (a) Ovarian cancer cells have distinct growth rates. 
For proliferation assay, cells were seeded in triplicates in 24-well plates and allowed to grow 
for different days as indicated. On the day of cell count, cells were trypsinized and counted 
using haemocytometer. Dots indicate experimental data while lines represent best-fitting of 
the experimental data using exponential equation. HaCaT cells-black dots and line, PEO1-red 
dots and line, PEO4-green dots and line, PEO6-magenta dots and line, OVCAR3-brown dots 
and line, OVCAR4-pink dots and line. Data are the means and standard error (bars) of n=3 
independent experiments performed in triplicates. (b) Ovarian cancer cells show elevated but 
dissimilar levels of total reactive oxygen species (ROS). Cells seeded for 18hrs in opaque flat 
bottom 96-well plates were either treated with DMSO only or CELLROX®green reagent to 
assay for basal ROS as described in materials and methods. ROS was measured as 
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fluorescence signal using 96-well plate fluorescence multiplate reader (MODULUS
TM
, 
Promega) using 485/520 nm filter set. Data are the means and standard error (bars) of 
experiments performed in quadruplicates.  (c) Cells were seeded and treated as above and 
imaged under 485/520 nm filter set with a Leica DMiRe2 electronic microscope. These are 
representative images captured using 5x objective. Scale bar represents 50µm.  
 
Figure 3: NRF2 and KEAP1 protein expression is different among ovarian cancer cell 
lines. (a) Immunoblotting analysis of constitutive levels of total NRF2 and KEAP1 show 
variation among human keratinocytes and panel of ovarian cancer cell lines. Exponentially 
growing cells were harvested and protein lysates prepared and further processed for 
immunoblotting as mentioned in materials and methods using relevant antibodies (Table 1). 
For loading control, β-actin antibody was used. (b) Bar chart showing NRF2 and KEAP1 
protein abundance in different cells expressed in nanograms (ng) by quantifying immunoblot 
signal intensities obtained in (a) and by utilising standard curve of immunoblot signals as 
established in Supplementary fig 3. The signal intensities were quantified through integrated 
optical densitometry measurement using Gelpro software (Version 3.1, Media Cybernetics). 
Data presented in all panels are the mean with standard error (bars) of n=3 independent 
experiments.  
Figure 4: Normal and ovarian cancer cell lines exhibit differences in sub-cellular 
localisation of endogenous basal NRF2. (a) Immunoblotting following sub-cellular protein 
fractionation revealed nuclear protein abundance of NRF2 in most of the ovarian cancer cell 
lines studied. Cells grown on 60mm plates were harvested and protein lysates fractionated 
into nuclear (N) and cytoplasmic (C) fractions and subjected to immunoblotting using anti 
NRF2 antibody (table 1). (b) The immunoblot signal intensities obtained in (a) were 
53 
 
subjected to semi quantitative analysis through integrated optical densitometry measurement 
using Gelpro software (Version 3.1, Media Cybernetics). Signal intensity from each fraction 
of a cell line was represented as % abundance of total signal from the two fractions 
(considered as 100%). Data presented in all panels are the mean of n=3 independent 
experiments. (c) Immunofluorescent labelling of endogenous NRF2 reveals predominantly 
nuclear localisation in most of the ovarian cancer cell lines studied. Cells grown on poly-L 
lysine coated coverslips were processed for immunocytochemistry as described in materials. 
To immunolabel endogenous NRF2, anti NRF2 primary antibody (table 1) followed by Alexa 
Fluor® 488/568 conjugated goat anti-rabbit secondary antibody (green fluorescence) was 
used. Staining of F-Actin filaments was performed by using Alexa fluor® 568 conjugated 
Phalloidin (Invitrogen) and capturing image with 578/600nm filter set (red fluorescence). 
Cytoplasmic localisation was confirmed by performing colocalisation of immunolabelled 
NRF2 with F-Actin using integrated features of ANDOR iQ core software (ANDOR 
Technologies Ltd). Scale bar indicates 10µm. These are representative images taken in 
different field of views with 100x objective with Leica DMiRe2 electronic microscope.  
 
Figure 5: Protein stability of endogenous NRF2 exhibits differences in ovarian cancer cell 
lines and is enhanced as compared to HaCat cells.  (a) Immunoblotting for total NRF2 
following treatment with 50µM Cycloheximide (Sigma) revealed differences in basal NRF2 
protein stability among cell lines. Cells were either left untreated (0) or treated with  
cycloheximide for different time points indicated in minutes (min) and protein lysates 
processed for immunoblot analysis of total NRF2 using anti NRF2 antibody (table 1) (b) The 
immunoblot signal intensities obtained in (a) were subjected to semi quantitative analysis 
through integrated optical densitometry measurement using Gelpro software (Version 3.1, 
Media Cybernetics). Dots are mean signal intensities represented as a fraction of the signal 
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obtained at time 0 (set as 1). Lines represent the result of the best-fitting of the experimental 
data by two-exponential equations. HaCaT cells – black line and points, PEO1 – red, SKOV3 
– blue, PEO6 - green, OVCAR3 – brown, PEO4 – magenta and OVCAR4 – grey.  
 
Figure 6: Ovarian cancer cells show faster but dissimilar kinetics of exogenous ROS 
scavenging illustrating a robust antioxidant signalling response. Time dependent H2O2 
neutralisation assay was performed following challenge with 5µM H2O2 followed by either 
immediately performing H2O2 detection assay (time 0) or at different time points following 
treatment as indicated in figure and described in materials and methods. The data obtained 
was normalised to represent actual Nanomolar H2O2 levels (nM) established through standard 
curve of H2O2 and are the mean with standard error (bars) performed in quadruplicates for 
each treatment.  
 
Figure 7: Treatment with antioxidant N-Acetyl Cysteine or ROS inducing H2O2 causes 
distinctive time dependent changes in sub-cellular localization and total NRF2 levels in 
cell lines indicating dissimilar kinetics of antioxidant response. Time course treatment with 
10mM N-Acetyl cysteine (NAC) caused disappearance of NRF2 from cytoplasm with overall 
reduction in total NRF2 while H2O2 induced its nuclear accumulation. Cells grown on poly-L 
lysine (Sigma-Aldrich) coated cover slips were either left untreated (time 0) or exposed to 
10mM NAC or 100µM H2O2. At indicated time points represented in minutes (min), 
treatments were stopped and coverslips processed for immunocytochemistry. To stain for 
endogenous NRF2, anti NRF2 primary antibody (table 1) followed by Alexa Fluor® 488/568 
conjugated goat anti-rabbit secondary antibody (green fluorescence) was used. Staining of F-
Actin filaments was performed by using Alexa fluor® 568 conjugated Phalloidin (Invitrogen) 
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and capturing image with 578/600nm filter set (red fluorescence). Cytoplasmic localisation 
was confirmed by performing colocalisation of immunolabelled NRF2 with F-Actin filaments 
using integrated features of ANDOR iQ core software (ANDOR Technologies Ltd) while 
nuclear reference was provided by co-staining with 4',6-Diamidino-2-Phenylindole, 
Dihydrochloride (DAPI). Panels a, d & g are representative images taken with relevant filter 
sets and captured in different field of views with 100x objective with Leica DMiRe2 
electronic microscope with scale bar representing 10µm. Bar charts in panels b, c (PEO1) e, f 
(HaCaT) & h, I (OVCAR3) represent immunofluorescent intensity measurements of either 
total NRF2 immunostaining (black bars) or of individual intensities obtained from nuclear 
and cytoplasmic compartments (blue and red bars respectively) using integrated features of 
Andor IQ core software (ANDOR Technologies Ltd). Values represent mean fluorescent 
intensities of either single cells or nuclear and cytoplasmic fractions of at least 10 cells per 
slide for a treatment in different field of views and normalised to total fluorescence from 
untreated controls (UT) set as 100%.  
 
Figure 8: Scavenging basal ROS causes inhibition of proliferation in ovarian cancer cell 
lines but not in HaCat cells. Exponentially growing cells in normal media were either treated 
with media alone, with media containing 10mM ROS scavenging agent N-Acetyl Cysteine 
(NAC) or 20µM of the pro-oxidant H2O2. On the indicated days, cells were trypsinized and 
counted using haemocytometer. Data are the means and standard error (bars) of experiments 
performed in triplicates.  
 
Figure 9: Computational results for H2O2 degradation kinetics in extracellular medium 
(black line), reduced, Pxred  (magenta line), oxidised Pxox (blue line), and total Pxtot (red line) 
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peroxidase following addition of 5 mM H2O2 at time t=0. Points – experimental data for 
HaCaT (black square) and OVCAR3 (black circle) cells.  
Figure 10: Computational results for degradation kinetics of total (black lines), nuclear (blue 
lines), and cytoplasmic (red lines) NRF2 following cycloheximide treatment of HaCaT (a) 
and PE01 (b) cells.  Points – experimental data for HaCaT (a) and PE01 (b) cells. NRF2 
concentration is normalized to its basal level. 
 
 
Figure 11: Computational results for total (black lines), nuclear (blue lines), and cytoplasmic 
(red lines) NRF2 kinetics under 100 μM H
2
O
2
 (a) and 10 mM N-acetyl cysteine (NAC) (b) 
treatments. Points – experimental data for HaCaT cells. Nuclear and cytoplasmic NRF2 
fractions are normalized to the total concentration.  
 
 
Figure 12:  The Nrf2-H
2
O
2 
regulation curve. The theoretical dependence of total (black line) 
and nuclear (blue line) concentrations of Nrf2 on endogenous level of H
2
O
2
. Point – 
experimental data on total (black points) and nuclear (blue points) concentration of Nrf2 in 
seven cell lines (in arbitrary units).  
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